Avida Biomed

Avida Biomed is an early-stage life science company that develops high-performance targeted enrichment workflows with unique capabilities for clinical researchers utilizing next-generation sequencing (NGS) methods to study cancer. The company aims to advance molecular diagnostics through innovation and integration of genomic tools. Avida Biomed’s technology will enable scientists working in precision medicine to develop novel approaches for a variety of applications, including biomarker discovery, patient selection for clinical trials, diagnosis and prognosis, treatment selection, and disease recurrence.